Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.
Sterols are constituents of the cellular membranes that are essential for their normal structure and function. In mammalian cells, cholesterol is the main sterol found in the various membranes. However, other sterols predominate in eukaryotic microorganisms such as fungi and protozoa. It is now well established that an important metabolic pathway in fungi and in members of the Trypanosomatidae family is one that produces a special class of sterols, including ergosterol, and other 24-methyl sterols, which are required for parasitic growth and viability, but are absent from mammalian host cells. Currently, there are several drugs that interfere with sterol biosynthesis (SB) that are in use to treat diseases such as high cholesterol in humans and fungal infections. In this review, we analyze the effects of drugs such as (a) statins, which act on the mevalonate pathway by inhibiting HMG-CoA reductase, (b) bisphosphonates, which interfere with the isoprenoid pathway in the step catalyzed by farnesyl diphosphate synthase, (c) zaragozic acids and quinuclidines, inhibitors of squalene synthase (SQS), which catalyzes the first committed step in sterol biosynthesis, (d) allylamines, inhibitors of squalene epoxidase, (e) azoles, which inhibit C14alpha-demethylase, and (f) azasterols, which inhibit Delta(24(25))-sterol methyltransferase (SMT). Inhibition of this last step appears to have high selectivity for fungi and trypanosomatids, since this enzyme is not found in mammalian cells. We review here the IC50 values of these various inhibitors, their effects on the growth of trypanosomatids (both in axenic cultures and in cell cultures), and their effects on protozoan structural organization (as evaluted by light and electron microscopy) and lipid composition. The results show that the mitochondrial membrane as well as the membrane lining the protozoan cell body and flagellum are the main targets. Probably as a consequence of these primary effects, other important changes take place in the organization of the kinetoplast DNA network and on the protozoan cell cycle. In addition, apoptosis-like and autophagic processes induced by several of the inhibitors tested led to parasite death.
de Souza
Wanderley
W
Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísicia Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, CCS-Bloco G, 21941-902, Rio de Janeiro, RJ, Brazil.
Rodrigues
Juliany Cola Fernandes
JC
Vet Parasitol. 2007 May 15;146(1-2):25-34
17367936
Science. 1996 Aug 16;273(5277):969-71
8688084
Plant Physiol. 2000 Apr;122(4):1045-56
10759500
Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):35-45
12467972
Mol Cell Biol. 1989 Aug;9(8):3447-56
2677674
Antimicrob Agents Chemother. 1990 Nov;34(11):2097-105
2073100
Arch Biochem Biophys. 1998 Feb 15;350(2):283-90
9473303
Exp Parasitol. 2005 Dec;111(4):230-8
16198340
Antimicrob Agents Chemother. 2007 Nov;51(11):4049-61
17709461
BMC Microbiol. 2009 Apr 20;9:74
19379501
EMBO J. 2003 Nov 17;22(22):6016-26
14609948
Biochem Biophys Res Commun. 1986 May 14;136(3):851-6
3521598
Chemotherapy. 1996 Jul-Aug;42(4):294-307
8804798
Mol Biochem Parasitol. 2008 Jul;160(1):52-9
18485498
J Biol Chem. 2007 Oct 19;282(42):30804-16
17724033
Protist. 2007 Oct;158(4):447-56
17719843
Biochem Pharmacol. 1996 Jun 14;51(11):1477-87
8630089
J Submicrosc Cytol Pathol. 2003 Jul;35(3):287-94
14690177
Annu Rev Pharmacol Toxicol. 1998;38:375-88
9597160
Mol Biochem Parasitol. 1988 Nov;31(2):149-62
2847043
Antimicrob Agents Chemother. 1984 Apr;25(4):483-7
6375557
Int J Biochem Cell Biol. 2009 Oct;41(10):2069-80
19379828
Curr Pharm Des. 2008;14(9):882-8
18473837
Mol Biochem Parasitol. 2003 Feb;126(2):129-42
12615312
Arch Biochem Biophys. 1976 May;174(1):45-51
7207
Drugs. 2007;67(1):11-6
17209661
Toxicology. 2002 Dec 27;181-182:471-4
12505355
Antimicrob Agents Chemother. 2000 Jan;44(1):150-5
10602737
Int J Antimicrob Agents. 2004 Jul;24(1):72-8
15225865
Bioorg Med Chem. 2005 May 16;13(10):3519-29
15848765
Antimicrob Agents Chemother. 1997 Jul;41(7):1428-32
9210660
J Biol Chem. 1988 Jan 25;263(3):1301-6
3335546
Antimicrob Agents Chemother. 2009 Apr;53(4):1403-10
19164149
J Eukaryot Microbiol. 1995 Jul-Aug;42(4):337-46
7620457
Eukaryot Cell. 2003 Aug;2(4):756-68
12912895
J Med Chem. 2003 Oct 23;46(22):4714-27
14561091
Biochim Biophys Acta. 1995 Sep 13;1238(2):163-76
7548131
J Cell Biol. 1986 Sep;103(3):875-86
3745272
Annu Rev Microbiol. 1995;49:607-39
8561474
FEMS Microbiol Lett. 2006 Feb;255(1):33-42
16436059
Comp Biochem Physiol. 1969 Aug 15;30(4):601-10
5356613
Antimicrob Agents Chemother. 2004 Jul;48(7):2379-87
15215084
Int J Antimicrob Agents. 2004 Mar;23(3):273-85
15164969
Mol Biochem Parasitol. 1984 Feb;10(2):161-70
6700638
Antimicrob Agents Chemother. 1998 Jul;42(7):1771-7
9661019
J Med Chem. 2001 Mar 15;44(6):909-16
11300872
Curr Drug Targets Infect Disord. 2001 May;1(1):51-61
12455233
Antimicrob Agents Chemother. 2002 Feb;46(2):487-99
11796362
Plant Physiol. 1996 Jun;111(2):619-26
8787029
J Biol Chem. 1984 Feb 10;259(3):1661-6
6420412
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):89-102
11111079
Biochem Pharmacol. 1985 Oct 15;34(20):3785-8
4052119
J Eukaryot Microbiol. 2001 Sep-Oct;48(5):588-94
11596924
Antimicrob Agents Chemother. 1999 Dec;43(12):2910-4
10582881
Bioorg Med Chem. 2008 Mar 15;16(6):3283-90
18096393
Int J Antimicrob Agents. 1996 Oct;7(4):235-40
18611761
Parasitology. 1997;114 Suppl:S91-9
9309771
Antimicrob Agents Chemother. 2004 Aug;48(8):2937-50
15273104
Antimicrob Agents Chemother. 2008 Nov;52(11):4098-114
18765694
Antimicrob Agents Chemother. 2002 Mar;46(3):929-31
11850291
J Med Chem. 2006 Feb 9;49(3):892-9
16451055
J Cell Sci. 2005 Jan 15;118(Pt 2):283-90
15654017
Comp Biochem Physiol B. 1972 Jan 15;41(1):1-18
4561635
Mol Biochem Parasitol. 1995 Jul;73(1-2):199-210
8577328
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4012-6
2438691
Antimicrob Agents Chemother. 1988 Aug;32(8):1237-42
3056256
Prog Histochem Cytochem. 2009;44(2):67-124
19410686
Biochem J. 1995 May 15;308 ( Pt 1):31-8
7755579
Nat Rev Microbiol. 2005 Mar;3(3):251-61
15738951
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6753-7
3413122
FEMS Microbiol Lett. 1991 Apr 15;63(2-3):127-31
2060756
Int J Parasitol. 2009 Feb;39(3):307-14
18848949
J Antimicrob Chemother. 2000 Jul;46(1):137-40
10882704
Parasitol Res. 1991;77(6):461-8
1656428
Mol Biochem Parasitol. 2006 Jun;147(2):193-206
16546274
J Lipid Res. 2000 Dec;41(12):1921-35
11108725
J Infect Dis. 2002 Jul 1;186(1):138-40
12089677
Antimicrob Agents Chemother. 1991 Apr;35(4):736-40
2069380
Antimicrob Agents Chemother. 2003 Sep;47(9):2966-70
12937003
Curr Opin Microbiol. 2007 Dec;10(6):539-46
17997129
Antimicrob Agents Chemother. 1993 Mar;37(3):580-91
8460926
Int J Antimicrob Agents. 2004 Mar;23(3):286-90
15164970
Curr Pharm Des. 2008;14(9):925-38
18473841
Micron. 2009 Feb;40(2):157-68
18849169
Mol Biochem Parasitol. 1999 Oct 25;104(1):81-91
10589983
Curr Pharm Des. 2002;8(4):297-318
11860368
J Biol Chem. 1997 Jun 13;272(24):15381-8
9182568
J Med Chem. 1996 Jul 19;39(15):2971-9
8709131
Mol Biochem Parasitol. 1989 Jan 15;32(2-3):179-89
2494453
Prog Lipid Res. 1993;32(4):357-416
8309949
Int J Parasitol. 2001 May 1;31(5-6):472-81
11334932
Annu Rev Microbiol. 1999;53:629-55
10547703
Eukaryot Cell. 2006 Jul;5(7):1057-64
16835450
Rev Recent Clin Trials. 2006 May;1(2):143-53
18473965
Mol Microbiol. 2005 Mar;55(5):1566-78
15720561
Mol Biol Cell. 2004 Mar;15(3):1356-63
14699057
Antimicrob Agents Chemother. 2006 Aug;50(8):2595-601
16870747
Antimicrob Agents Chemother. 2007 Jun;51(6):2123-9
17371809
J Med Chem. 2005 Apr 21;48(8):2957-63
15828834
Mol Biochem Parasitol. 1985 Jun;15(3):257-79
4033689